Fibrosis research: Advances and challenges
Drug Discovery World
JANUARY 24, 2024
Fibrocor is on track to complete all IND-enabling work to support IND filing and initiation of clinical trials in 2024. Phase I of the clinical program will dose healthy volunteers with single ascending doses of FIB992 before proceeding to a multiple ascending dose study where the drug is administered for a two-week period.
Let's personalize your content